Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia
Younger children were underrepresented among those treated for MDR/RR-TB, indicating reduced access to care. Severe AEs were uncommon during MDR/RR-TB treatment. Baseline indicators of extensive disease were associated with all-cause mortality. The high proportion of pre-treatment mortality and LTFU may reflect complex patient pathways limiting access to care.
Authors
- Jan‐Willem C. Alffenaar (ORCID: https://orcid.org/0000-0001-6703-0288)
- Chindy Arya Sari
- Ben J. Marais (ORCID: https://orcid.org/0000-0003-3404-2690)
- Heda Melinda Nataprawira (ORCID: https://orcid.org/0000-0001-8079-6544)
- Fajri Gafar (ORCID: https://orcid.org/0000-0002-0084-9018)
- Rovina Ruslami (ORCID: https://orcid.org/0000-0003-4995-5054)
- Dick Menzies
Institutions
- The University of Sydney (AU)
- Taronga Conservation Society Australia (AU)
- McGill University Health Centre (CA)
- Children's Hospital at Westmead (AU)
- Westmead Hospital (AU)
- Dr. Hasan Sadikin General Hospital (ID)
- McGill University (CA)
- Padjadjaran University (ID)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1097/inf.0000000000004539
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Fonds de Recherche du Québec - Santé